Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Carcinoma, Hepatocellular 7Neoplasm Metastasis 5Colorectal Neoplasms 5Advanced Solid Tumor 4Squamous Cell Carcinoma of Head and Neck 3Solid Tumor 3Small Cell Lung Carcinoma 3Lung Neoplasms 3Esophageal Squamous Cell Carcinoma 3Stomach Neoplasms 2Rectal Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Transitional Cell 2Advanced Solid Tumour 2Unresectable Stage III Non-small Cell Lung Cancer 1Triple Negative Breast Neoplasms 1Skin Neoplasms 1Simpson-Golabi-Behmel syndrome 1Recurrence 1Patients With Initially Unresectable MSS-type Advanced Colorectal Cancer With Liver and/or Lung and Peritoneal Metastasis 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm, Residual 1Metastatic Solid Tumors 1Melanoma 1MSI-H/dMMR Solid Tumors 1Lymphoma, Extranodal NK-T-Cell 1

Interventions

Oxaliplatin 30Fluorouracil 23Capecitabine 19Nivolumab 17pembrolizumab 16Leucovorin 16Docetaxel 10Paclitaxel 9Drug Therapy 9Cisplatin 9Trastuzumab 8S 1 (combination) 8Specimen Handling 7trastuzumab deruxtecan 6fludarabine 6Cyclophosphamide 6Bevacizumab 6Magnetic Resonance Spectroscopy 5Biopsy 5zolbetuximab 4Radiotherapy 4Irinotecan 4Carboplatin 4zimberelimab 3sintilimab 3olaparib 3durvalumab 3atezolizumab 3aldesleukin 3XELOX 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Stomach Neoplasms × tislelizumab × 90 days × Clear all
NCT05152147 2026-05-19

HERIZON-GEA-01

Jazz Pharmaceuticals

Phase 3 Active not recruiting
920 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms, Stomach Neoplasms

NCT05768932 2026-03-27

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

SillaJen, Inc.

Phase 1 Recruiting
260 enrolled
BreastGastrointestinalOther hematologic neoplasm

Carcinoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡